Fully automated dose prediction using generative adversarial networks in prostate cancer patients.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 12 01 2020
accepted: 19 04 2020
entrez: 5 5 2020
pubmed: 5 5 2020
medline: 8 8 2020
Statut: epublish

Résumé

Although dose prediction for intensity modulated radiation therapy (IMRT) has been accomplished by a deep learning approach, delineation of some structures is needed for the prediction. We sought to develop a fully automated dose-generation framework for IMRT of prostate cancer by entering the patient CT datasets without the contour information into a generative adversarial network (GAN) and to compare its prediction performance to a conventional prediction model trained from patient contours. We propose a synthetic approach to translate patient CT datasets into a dose distribution for IMRT. The framework requires only paired-images, i.e., patient CT images and corresponding RT-doses. The model was trained from 81 IMRT plans of prostate cancer patients, and then produced the dose distribution for 9 test cases. To compare its prediction performance to that of another trained model, we created a model trained from structure images. Dosimetric parameters for the planning target volume (PTV) and organs at risk (OARs) were calculated from the generated and original dose distributions, and mean differences of dosimetric parameters were compared between the CT-based model and the structure-based model. The mean differences of all dosimetric parameters except for D98% and D95% for PTV were within approximately 2% and 3% of the prescription dose for OARs in the CT-based model, while the differences in the structure-based model were within approximately 1% for PTV and approximately 2% for OARs, with a mean prediction time of 5 seconds per patient. Accurate and rapid dose prediction was achieved by the learning of patient CT datasets by a GAN-based framework. The CT-based dose prediction could reduce the time required for both the iterative optimization process and the structure contouring, allowing physicians and dosimetrists to focus their expertise on more challenging cases.

Identifiants

pubmed: 32365088
doi: 10.1371/journal.pone.0232697
pii: PONE-D-20-01032
pmc: PMC7197852
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232697

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Am Coll Radiol. 2009 Jul;6(7):514-7
pubmed: 19560069
Radiother Oncol. 2007 Jul;84(1):5-10
pubmed: 17493700
J Appl Clin Med Phys. 2016 Nov 08;17(6):78-85
pubmed: 27929483
Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):981-990
pubmed: 27302513
Transl Cancer Res. 2016 Aug;5(4):432-447
pubmed: 29188191
Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1456-62
pubmed: 19540062
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):731-6
pubmed: 9112473
Comput Med Imaging Graph. 2019 Jan;71:30-39
pubmed: 30472408
Radiat Oncol. 2018 Sep 10;13(1):170
pubmed: 30201017
Phys Med. 2019 Jan;57:231-237
pubmed: 30545736
Sci Rep. 2019 Jan 31;9(1):1076
pubmed: 30705354
Phys Med Biol. 2018 Dec 04;63(23):235022
pubmed: 30511663
Med Phys. 2020 Mar;47(3):837-849
pubmed: 31821577
Med Phys. 2019 Feb;46(2):550-562
pubmed: 30449055
Med Phys. 2019 Aug;46(8):3679-3691
pubmed: 31102554
J Radiat Res. 2018 May 1;59(3):327-332
pubmed: 29800456
Med Phys. 2019 Jan;46(1):370-381
pubmed: 30383300
Radiat Oncol. 2015 Oct 31;10:220
pubmed: 26521015
Radiat Oncol. 2018 Mar 20;13(1):46
pubmed: 29558940
Phys Med. 2019 Aug;64:174-181
pubmed: 31515017
Jpn J Radiol. 2017 May;35(5):269-278
pubmed: 28281047
Sensors (Basel). 2019 May 22;19(10):
pubmed: 31121961
Med Phys. 2020 Feb;47(2):297-306
pubmed: 31675444
BMC Med Imaging. 2015 Aug 05;15:27
pubmed: 26242589
BMC Med Imaging. 2018 May 16;18(1):16
pubmed: 29769042
Phys Med Biol. 2019 Mar 18;64(6):065020
pubmed: 30703760
Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):612-20
pubmed: 25680603

Auteurs

Yu Murakami (Y)

Graduate Division of Health Sciences, Komazawa University, Komazawa, Setagaya-ku, Tokyo, Japan.
Radiation Oncology Department, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo, Japan.

Taiki Magome (T)

Graduate Division of Health Sciences, Komazawa University, Komazawa, Setagaya-ku, Tokyo, Japan.

Kazuki Matsumoto (K)

Graduate Division of Health Sciences, Komazawa University, Komazawa, Setagaya-ku, Tokyo, Japan.

Tomoharu Sato (T)

Radiation Oncology Department, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo, Japan.

Yasuo Yoshioka (Y)

Radiation Oncology Department, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo, Japan.

Masahiko Oguchi (M)

Radiation Oncology Department, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH